<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: 667, L.P. -->
          <cik>0001551139</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001603454</issuerCik>
      <issuerName>Celcuity Inc.</issuerName>
      <secFileNumber>001-38207</secFileNumber>
      <issuerAddress>
        <com:street1>2800 Campus Drive</com:street1>
        <com:street2>Suite 140</com:street2>
        <com:city>Minneapolis</com:city>
        <com:stateOrCountry>MN</com:stateOrCountry>
        <com:zipCode>55441</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>763-392-0123</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>667, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Former Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Goldman Sachs &amp; Co. LLC</name>
        <address>
          <com:street1>200 West Street</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10282</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>261368</noOfUnitsSold>
      <aggregateMarketValue>26790220.00</aggregateMarketValue>
      <noOfUnitsOutstanding>48766288</noOfUnitsOutstanding>
      <approxSaleDate>07/14/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>05/16/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Purchases of shares of common stock in the open market See Remark 2</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Purchases from counterparties in open market transactions</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>261368</amountOfSecuritiesAcquired>
      <paymentDate>05/19/2025</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>(1) 667, L.P. is affiliated with Baker Brothers Life Sciences, L.P. Baker Bros. Advisors LP serves as the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P. Baker Brothers Life Sciences, L.P. is filing separately for the sale of 2,838,632 shares of common stock ("Common Stock") of Celcuity Inc. (the "Issuer"), which along with the reported sales in this form by 667, L.P. totals 3,100,000 shares of Common Stock. (2) Shares of common stock to be sold were purchased between 5/16/2025 and 1/7/2025 in various open market transactions.</remarks>
    <noticeSignature>
      <noticeDate>07/14/2026</noticeDate>
      <signature>By: BAKER BROS. ADVISORS LP, mgmt company and IA to 667, L.P., /s/ Scott L. Lessing, President</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
